Park Avenue Securities LLC trimmed its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 21.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,771 shares of the company’s stock after selling 7,102 shares during the quarter. Park Avenue Securities LLC’s holdings in Corteva were worth $1,727,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Total Investment Management Inc. acquired a new stake in shares of Corteva in the 2nd quarter valued at $27,000. Activest Wealth Management raised its holdings in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares in the last quarter. JPL Wealth Management LLC acquired a new position in shares of Corteva during the 3rd quarter worth $25,000. True Wealth Design LLC lifted its position in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in Corteva in the second quarter valued at about $29,000. 81.54% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have commented on CTVA. Royal Bank Of Canada boosted their target price on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Mizuho raised their price target on shares of Corteva from $80.00 to $82.00 and gave the company an “outperform” rating in a research note on Tuesday, February 17th. Wolfe Research lifted their price target on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and upped their price objective for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Finally, Jefferies Financial Group increased their price objective on shares of Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, March 2nd. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $82.90.
Insider Transactions at Corteva
In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.15% of the company’s stock.
Corteva Price Performance
Corteva stock opened at $80.46 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $54.01 billion, a PE ratio of 50.92, a P/E/G ratio of 2.66 and a beta of 0.72. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $81.12. The stock has a 50-day moving average price of $75.51 and a two-hundred day moving average price of $69.44.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the previous year, the business posted $0.32 earnings per share. The business’s quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.
Corteva Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva’s dividend payout ratio is 45.57%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
